SLC7A11, as an essential amino acid transporter that promotes cysteine supply and GSH synthesis, is a core regulator of the cellular ferroptosis defense system and is a promising therapeutic target in cancer therapy [58]. This evidence concerns the gene SLC38A7 and cancer.